Molecule Information
General Information of the Molecule (ID: Mol02172)
Name |
HNF1A antisense RNA 1 (HNF1A-AS1)
,Homo sapiens
|
||||
---|---|---|---|---|---|
Synonyms |
HNF1A-AS1
Click to Show/Hide
|
||||
Molecule Type |
LncRNA
|
||||
Gene Name |
HNF1A-AS1
|
||||
Gene ID | |||||
Location |
chr12:120,941,728-120,980,968[-]
|
||||
Ensembl ID | |||||
HGNC ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
EADR: Epigenetic Alteration of DNA, RNA or Protein
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
Acetaminophen
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Epigenetic Alteration of DNA, RNA or Protein (EADR) | ||||
Disease Class: Cholangiocarcinoma | [1] | |||
Resistant Disease | Cholangiocarcinoma [ICD-11: 2C12.0] | |||
Resistant Drug | Acetaminophen | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
In Vitro Model | HepaRG cells | Liver | Homo sapiens (Human) | CVCL_9720 |
Experiment for Molecule Alteration |
Knockdown assay | |||
Experiment for Drug Resistance |
MTT assay | |||
Mechanism Description | Altogether, our study suggests that HNF1alpha-AS1 and HNF4alpha-AS1 affected AILI mainly through alterations of P450-mediated APAP biotransformation in HepaRG cells, indicating an important role of the LncRNAs in AILI. |
Disease- and Tissue-specific Abundances of This Molecule
ICD Disease Classification 02
Liver cancer [ICD-11: 2C12]
Differential expression of molecule in resistant diseases | ||
The Studied Tissue | Bile duct | |
The Specified Disease | Cholangiocarcinoma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 1.95E-01; Fold-change: -7.09E-02 | |
Molecule expression in the diseased tissue of patients
Molecule expression in the normal tissue of healthy individuals
|
||
Disease-specific Molecule Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Liver | |
The Specified Disease | Liver hepatocellular carcinoma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 1.16E-15; Fold-change: -1.05E-01 | |
Molecule expression in the diseased tissue of patients
Molecule expression in the normal tissue of healthy individuals
|
||
Disease-specific Molecule Abundances | Click to View the Clearer Original Diagram | |
Tissue-specific Molecule Abundances in Healthy Individuals
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.